HealthStream Inc. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits

false 0001095565 0001095565 2025-03-07 2025-03-07

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Registrant’s Telephone Number, Including Area Code: 615-301-3100

 

 

 

 

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instructions A.2. below):

 

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

 

Emerging growth company ☐

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 

 

On March 7, 2025, the Board of Directors (the “Board”) of HealthStream, Inc. (the “Company”) appointed Charles E. Beard, Jr. as a member of the Board. It is contemplated that Mr. Beard will commence service on the Board effective March 7, 2025. Mr. Beard will be a Class I Director, and as such his term will expire at the 2028 annual meeting of the Company’s shareholders. Moreover, it is contemplated that Mr. Beard will serve as a member of the Board’s Audit Committee.

 

Mr. Beard will participate in the standard non-employee director compensation arrangements described in the Company’s 2024 proxy statement, filed with the Securities and Exchange Commission on April 11, 2024. There are no arrangements or understandings between Mr. Beard and any other person pursuant to which he was selected to serve on the Board. There are no transactions and no proposed transactions between Mr. Beard and the Company that would require disclosure under Item 404(a) of Regulation S-K.

 

The Company’s press release announcing the appointment is attached as Exhibit 99.1 to this Current Report and is incorporated by reference herein.

 

 

(d) Exhibits.

 

 

 

 

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.